Atlas Trials

Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective

Clinical trial NCT01873248 · COMPLETED

Trial details

NCT number
NCT01873248
Sponsor
Jonsson Comprehensive Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2013-08-26
Primary completion
2017-06-16
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.